---
title: "AMICUS THERAPEUTICS INTERNATIONAL HOLDING LTD — Ownership Dossier"
canonical: https://whiteintel.dev/entity/2ab8448a-df09-5558-bb7b-4178174ac741
json: https://whiteintel.dev/api/public/dossier/2ab8448a-df09-5558-bb7b-4178174ac741
identifier: oo:GB-COH-10147996
jurisdiction: GB
risk: Low
source: WhiteIntel corporate-ownership graph
---

# AMICUS THERAPEUTICS INTERNATIONAL HOLDING LTD

**Type:** Company  
**Jurisdiction:** [GB](https://whiteintel.dev/jurisdictions/gb)  
**Identifier:** `oo:GB-COH-10147996`  
**Risk level:** Low  
**Canonical dossier:** https://whiteintel.dev/entity/2ab8448a-df09-5558-bb7b-4178174ac741  
**Structured JSON / MCP:** https://whiteintel.dev/api/public/dossier/2ab8448a-df09-5558-bb7b-4178174ac741  

## Ownership & control

### Owners / controllers

- **Amicus Therapeutics Inc** (beneficial owner) — 87.5% — https://whiteintel.dev/entity/21d3b1b4-dfa1-4b5c-b987-1594c2484280

### Holdings / subsidiaries

- **AMICUS THERAPEUTICS UK LIMITED** (beneficial owner) — 100% — https://whiteintel.dev/entity/80825649-e2e2-5f67-a276-63788722134b
- **AMICUS THERAPEUTICS UK LIMITED** (beneficial owner) — 87.5% — https://whiteintel.dev/entity/80825649-e2e2-5f67-a276-63788722134b

### UBO chain (walk to the ultimate owner)

A **1-step** ownership/control chain to the ultimate beneficial owner is resolved for this entity. The full cited chain unlocks with a paid API key or a one-off dossier — https://whiteintel.dev/pricing.

## Company profile (live · UK Companies House)

- **Company number:** `10147996`
- **Status:** active
- **Type:** ltd
- **Incorporated:** 2016-04-26
- **Registered office:** 1 Globeside Fieldhouse Lane, Marlow, Buckinghamshire, SL7 1HZ, United Kingdom
- **SIC:** 86900

### Officers

- GREEN, Steven John — director · British · appointed 2020-06-01
- KEOGH, Brian — director · Irish · appointed 2026-06-04
- MORGAN, Chay Bradwen — director · British · appointed 2026-06-04
- MORRIS, Richard Gideon — director · British · appointed 2026-06-04
- GHYOOT, Geoffrey Marc Caroline — director · Belgian · appointed 2016-04-26 · resigned 2017-03-10
- MOCHAN, Lori Elizabeth — director · British · appointed 2018-05-04 · resigned 2020-02-21
- PROUT, Samantha Lynn — director · American · appointed 2018-05-04 · resigned 2024-02-01
- QUIMI, Daphne Elke — director · American · appointed 2021-12-01 · resigned 2024-01-29
- QUIMI, Daphne Elke — director · American · appointed 2016-04-26 · resigned 2018-05-04
- SARKARIA, Jasvinder Singh — director · British · appointed 2017-03-21 · resigned 2018-05-04
- STOCKWELL, Caroline Amelia — director · British · appointed 2024-04-18 · resigned 2026-06-30

### Beneficial owners (Persons with Significant Control)

- [Amicus Therapeutics Inc](https://whiteintel.dev/entity/21d3b1b4-dfa1-4b5c-b987-1594c2484280) — 75–100% shares · corporate PSC · United States — since 2016-04-26

## Provenance

- companies_house_bulk — https://find-and-update.company-information.service.gov.uk/company/10147996
- OpenOwnership — https://find-and-update.company-information.service.gov.uk/company/10147996

---

_This is the markdown-for-agents view of the WhiteIntel dossier for **AMICUS THERAPEUTICS INTERNATIONAL HOLDING LTD**. Human view: https://whiteintel.dev/entity/2ab8448a-df09-5558-bb7b-4178174ac741 · Structured JSON: https://whiteintel.dev/api/public/dossier/2ab8448a-df09-5558-bb7b-4178174ac741._

_Risk levels are heuristic investigative leads, not legal determinations of beneficial ownership. Every claim carries a source; an absent edge means "not yet observed in current sources", not "does not exist"._